Tu Xiongwen. Analysis of Adverse Reactions and Influencing Factors of Tigecycline in the Treatment of Severe Pneumonia[J]. Journal of Dali University, 2021, 6(8): 44-46.
〔1〕孙丹, 焦红梅, 李子芊, 等. 替加环素注射剂治疗多重
耐药菌感染老年危重症患者的疗效分析〔J〕. 中国临
床药理学杂志, 2017, 33(14): 1291-1294.
〔2〕ASTON S J. Pneumonia in the Developing World:
Characteristic Features and Approach to Management〔J〕.
Respirology, 2017, 22(7): 1276-1287.
〔3〕BROEKER A, WICHA S G, DORN C, et al. Tigecycline
in Critically Ill Patients on Continuous Renal
Replacement Therapy: A Population Pharmacokinetic
Study〔J〕. Crit Care, 2018, 22(1): 341-344.
〔4〕GUTIÉRREZ J M M, BORROMEO A R, DUEÑO A L,
et al. Clinical Epidemiology and Outcomes of Ventilator-
Associated Pneumonia in Critically Ill Adult Patients:
Protocol for a Large-Scale Systematic Review and
Planned Meta-Analysis〔J〕. Syst Rev, 2019, 8(1): 180.
〔5〕郭小芙. 替加环素联合头孢哌酮舒巴坦治疗泛耐药鲍
曼不动杆菌老年重症肺炎的疗效〔J〕. 国际感染病学
( 电子版), 2019, 8(2): 113-114.
〔6〕GONG J, SU D, SHANG J, et al. Efficacy and Safety of
High-Dose Tigecycline for the Treatment of Infectious
Diseases: A Meta-Analysis〔J〕. Medicine (Baltimore),
2019, 98(38): e17091.
〔7〕朱曼, 田小燕, 郭代红, 等. 替加环素药源性肝损伤与
胰腺炎的主动监测研究〔J〕. 中华医院感染学杂志,
2017, 27(20): 4581-4583.